05/14/2020 12:00 AM EDT
Source: Stanford University. Published: 5/14/2020. Unique questions and the standardized Perceived Stress Scale are used to assess psychological stress due to remote work during the COVID-19 crisis. The purpose is to measure the level of stress during this time and characterize it according to location, gender, income, and other factors. It includes confidential survey questions about homeschooling, dependent care, full-time remote work, and social distancing. Population: Adults only Length: 37 questions Time to Complete: 8-10 minutes Administered by: Self Administered Language(s): English, Spanish French, Italian, Japanese, Chinese (PDF)
05/14/2020 12:00 AM EDT
Source: Christopher Newport University (CNU). Published: 5/14/2020. Basic information The coronavirus anxiety scale (CAS) is a self-report mental health screener of dysfunctional anxiety associated with the coronavirus crisis. Because a significant number of people experience clinically significant fear and anxiety during an infectious disease outbreak, the CAS was developed to help clinicians and researchers efficiently identify cases of individuals functionally impaired by coronavirus-related anxiety. Psychometric properties Independent studies of adults residing across the United State have demonstrated that the CAS is a reliable instrument (αs > .90), with solid factorial (single-factor; invariant across sociodemographics) and construct (correlated with anxiety, depression, suicidal ideation, and drug/alcohol coping) validity. The diagnostic properties of the CAS (90% sensitivity and 85% specificity) are comparable to related screening instruments, such as the Generalized Anxiety Disorder-7. Scoring and interpretation Each item of the CAS is rated on a 5-point scale, from 0 (not at all) to 4 (nearly every day), based on experiences over the past two weeks. This scaling format is consistent with the DSM-5’s cross-cutting symptom measure. A CAS total score ≥ 9 indicates probable dysfunctional coronavirus-related anxiety. Elevated scores on a particular item or a high total scale score (≥ 9) may indicate problematic symptoms for the individual that might warrant further assessment and/or treatment. Clinical judgement should guide the interpretation of the CAS results. Length: 5 questions Time to Complete: Self Administered/Self Report Languages: English, Brazilian Portuguese, Hebrew, Korean, Polish, Portuguese, Romanian, Spanish, Turkish, Urdu Special Considerations: COVID-19 (PDF)
05/14/2020 12:00 AM EDT
Source: Christopher Newport University (CNU). Published: 5/14/2020. Basic information The Obsession with COVID-19 Scale (OCS) is a self-report mental health screener of persistent and disturbed thinking about COVID-19. Because the COVID-19 crisis affects nearly every aspect of a person’s life, the OCS was developed to help clinicians and researchers efficiently identify cases of individuals functionally impaired by their COVID-19 related thinking patterns. Psychometric properties The OCS was developed on two large samples of adults (n = 775; n = 398) residing across the United States. The OCS is a reliable instrument (αs > .83), with solid factorial (single-factor) and construct (correlated with coronavirus anxiety, spiritual crisis, alcohol/drug coping, extreme hopelessness, and suicidal ideation) validity. The diagnostic properties of the OCS (81% to 93% sensitivity and 73% to 76% specificity) are comparable to related screening instruments, such as the General Health Questionnaire (GHQ). Scoring and interpretation Each item of the OCS is rated on a 5-point scale, from 0 (not at all) to 4 (nearly every day), based on experiences over the past two weeks. This scaling format is consistent with the DSM-5’s cross-cutting symptom measure. An OCS total score ≥ 7 indicates probable dysfunctional thinking about COVID-19. Elevated scores on a particular item or a high total scale score (≥ 7) may indicate problematic symptoms for the individual that might warrant further assessment and/or treatment. Clinical judgement should guide the interpretation of the OCS results. Length: 4 questions Time to Complete: Self Administered/Self Report Languages: English, Hebrew, Korean, Polish, Romanian, Turkish, Urdu (PDF)
05/13/2020 12:00 AM EDT
Source: U.S. Government Accountability Office (GAO). Published: 5/13/2020. This two-page document provides information about social distancing, the still-developing science behind it, and how it saves lives by slowing disease transmission and reducing the load on the health care system in a pandemic such as COVID-19. The document discusses social distancing opportunities, challenges, and policy context and questions. (PDF)
05/13/2020 12:00 AM EDT
Source: U.S. Department of Homeland Security (DHS). Published: 5/13/2020. This predictive modeling tool estimates natural decay of SARS-CoV-2 (the virus that causes COVID-19) under a range of temperatures and relative humidity. Leveraging the results of research being conducted at the National Biodefense Analysis and Countermeasures Center (NBACC), the tool is designed to assist response efforts and estimate the environmental persistence of the virus under certain combinations of temperatures and humidity. (Text)
05/13/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 5/13/2020. This mobile app provides health workers everywhere with an efficient way to access the World Health Organization (WHO)'s COVID-19 knowledge resources all in one place, including up-to-the-minute guidance, tools, training, self-paced learning, and virtual workshops to support health workers in caring for patients infected by COVID-19 – as well on how they can protect themselves as they do their critical work. (Video or Multimedia)
05/13/2020 12:00 AM EDT
Source: Government of Canada. Published: 5/13/2020. This web page provides guidance for the continuity of immunization programs during the COVID-19 pandemic, when disruption of immunization services, even for short periods, will result in an accumulation of susceptible individuals, and a higher likelihood of vaccine-preventable disease (VPD) outbreaks. (Text)
05/12/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 5/12/2020. This 12-minute video can help healthcare leadership communicate in ways that mitigate stress in their staff working during the COVID-19 pandemic. It discusses organizational wellness, drivers of lasting motivation, and a stress audit checklist. (Video or Multimedia)
05/12/2020 12:00 AM EDT
Source: United States Interagency Council on Homelessness (USICH). Published: 5/12/2020. In this one-hour, 26-minute webinar, presenters from King County discuss providing medical, behavioral health, and substance use treatment in isolation and quarantine during the COVID-19 outbreak, and the response for people living homeless. (Video or Multimedia)
05/11/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/11/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the 1copy™ COVID-19 qPCR Multi Kit, which received an Emergency Use Authorization from the Food and Drug Administration on May 11, 2020. The 1copy™ COVID-19 qPCR Multi Kit is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
05/11/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/11/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Abbott Alinity m SARS-CoV-2 assay, which received an Emergency Use Authorization from the Food and Drug Administration on May 11, 2020. The Abbott Alinity m SARS-CoV-2 assay is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
05/11/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/11/2020. This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Eko ECG Low Ejection Fraction Tool (ELEFT). This software device for diagnosing low Left Ventricular Ejection Fraction (LVEF) is for use by healthcare professionals (HCP) to provide an assessment of LVEF for use as a diagnostic aid to screen for potential cardiac complication associated with COVID-19 or underlying cardiac conditions that may affect clinical management of COVID-19, in adult patients having or suspected of having COVID-19. (PDF)
05/11/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/11/2020. This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Ascom teleCARE IP Nurse Call System. During the COVID-19 outbreak, the remote communication and monitoring capabilities of the teleCARE IP Nurse Call System may reduce the amount of contact by healthcare providers with patients who are in isolation rooms, thereby reducing healthcare provider risk of exposure to SARS-CoV-2, the virus that causes COVID-19. (PDF)
05/11/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/11/2020. This web page provides answers to frequently asked questions about wildland firefighters and COVID-19. Topics include how to prevent infection and spread, prioritization of testing, and precautions wildland firefighters should take. (Text)
05/09/2020 12:00 AM EDT
Source: Resolve to Save Lives. Published: 5/9/2020. This playbook aims to provide clear and actionable technical guidance and tools for U.S. health departments to rapidly set up and implement contact tracing to support COVID-19 containment. It provides actionable technical guidance, including implementation checklists and tools, for each of the nine domains of a successful contact tracing program. (Text)
05/08/2020 12:00 AM EDT
Source: National Emerging Special Pathogens Training and Education Center (NETEC). Published: 5/8/2020. This one-hour webinar identifies strategies and innovative practices for the identification and management of COVID-19 patients and for safe continuity of care for all vulnerable populations. Topics include A Review of Basics and Case Review, and COVID-19 Experiences and Guidance in Nebraska Post-Acute and Long-Term Care. (Video or Multimedia)
04/24/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 4/24/2020. This 50-page document from the Health and Human Services/Federal Emergency Management Agency COVID-19 Healthcare Resilience Task Force offers flexible and modifiable guidance, developed by the U.S. government, aimed to assist regional, state, local, tribal, and territorial governments to ensure load-balancing across healthcare facilities and systems so that the highest possible level of care can be provided to each patient during the coronavirus disease 2019 (COVID-19) pandemic. Medical operations coordination cells are cells within emergency operations centers that facilitate patient movement, healthcare staffing, and life-saving resource allocation. (PDF)
04/17/2020 12:00 AM EDT
Source: United Nations Office for the Coordination of Humanitarian Affairs, Inter-Agency Standing Committee (IASC). Published: 4/17/2020. This five-page document outlines the "light" and "adapted" scale-up protocols to be activated for the Inter-Agency Standing Committee response to the COVID-19 emergency. It describes the collective approach and principles of action to guide the system-wide response. (PDF)
04/01/2020 12:00 AM EDT
Source: Trust for America's Health. Published: 4/2020. This web page provides information and links for webinars in the COVID-19 Special Issues and Responses series, starting on April 1, 2020. It will be updated as webinars are held. (Video or Multimedia)
No hay comentarios:
Publicar un comentario